创新-话题@MedSci

#创新#

1015篇内容 | 8143人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1286026, encodeId=c2d3128602673, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, objectType=article, longId=209815, objectId=a6962098152d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6962098152d, replyNumber=0, likeNumber=81, createdTime=2021-04-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6962098152d, moduleTitle=精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6962098152d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285990, encodeId=0ce21285990e7, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=以创新续写胰岛素百年传奇，赛诺菲助力糖尿病患者摆脱“甜蜜负担”, objectType=article, longId=209795, objectId=39f6209e9588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39f6209e9588, replyNumber=0, likeNumber=92, createdTime=2021-04-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39f6209e9588, moduleTitle=以创新续写胰岛素百年传奇，赛诺菲助力糖尿病患者摆脱“甜蜜负担”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39f6209e9588)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285989, encodeId=93211285989a0, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=长三角AI影像论坛在沪举行权威大咖力推AI临床创新, objectType=article, longId=209701, objectId=538a209e01f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=538a209e01f3, replyNumber=0, likeNumber=57, createdTime=2021-04-10, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=538a209e01f3, moduleTitle=长三角AI影像论坛在沪举行权威大咖力推AI临床创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=538a209e01f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285988, encodeId=5edc128598851, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=中国自主创新微球制剂瑞欣妥®上市，以全球领先微球技术提升精神分裂症临床获益, objectType=article, longId=209472, objectId=64002094e27d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64002094e27d, replyNumber=0, likeNumber=99, createdTime=2021-04-05, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64002094e27d, moduleTitle=中国自主创新微球制剂瑞欣妥®上市，以全球领先微球技术提升精神分裂症临床获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64002094e27d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285994, encodeId=e2f212859941e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=守护医护安全，创新质惠中国：碧迪医疗全球独创BD Vacutainer® V质管重磅上市, objectType=article, longId=208599, objectId=73ec2085995d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73ec2085995d, replyNumber=0, likeNumber=54, createdTime=2021-03-19, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73ec2085995d, moduleTitle=守护医护安全，创新质惠中国：碧迪医疗全球独创BD Vacutainer® V质管重磅上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73ec2085995d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285987, encodeId=4ab2128598ea6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=荣昌生物创新药泰它西普在中国正式获批, objectType=article, longId=208316, objectId=95a120831629, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95a120831629, replyNumber=0, likeNumber=32, createdTime=2021-03-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95a120831629, moduleTitle=荣昌生物创新药泰它西普在中国正式获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95a120831629)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285985, encodeId=68331285985ec, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=医美科技创新云第二届肉毒毒素联合论坛, objectType=article, longId=208311, objectId=177e2083113d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=177e2083113d, replyNumber=0, likeNumber=95, createdTime=2021-03-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=177e2083113d, moduleTitle=医美科技创新云第二届肉毒毒素联合论坛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=177e2083113d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285984, encodeId=ce1a128598424, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021RWE真实世界研究峰会（第五届）创新变革规范中国-上海 2021.04.23-24, objectType=article, longId=208280, objectId=6e4120828020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e4120828020, replyNumber=0, likeNumber=19, createdTime=2021-03-13, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e4120828020, moduleTitle=2021RWE真实世界研究峰会（第五届）创新变革规范中国-上海 2021.04.23-24, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e4120828020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285983, encodeId=e70d1285983d8, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=创新肺纤维化靶向药维加特®医保落地，患者自付费用大降90%, objectType=article, longId=208158, objectId=f16d20815805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f16d20815805, replyNumber=0, likeNumber=84, createdTime=2021-03-09, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f16d20815805, moduleTitle=创新肺纤维化靶向药维加特®医保落地，患者自付费用大降90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f16d20815805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285982, encodeId=ccdc12859826d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, objectType=article, longId=208138, objectId=ca0a2081382a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca0a2081382a, replyNumber=0, likeNumber=51, createdTime=2021-03-09, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca0a2081382a, moduleTitle=新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca0a2081382a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285981, encodeId=b48a12859814a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=Inovio宣布DNA免疫疗法治疗宫颈癌变创新药III期临床成功, objectType=article, longId=208135, objectId=11df20813559, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11df20813559, replyNumber=0, likeNumber=76, createdTime=2021-03-09, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11df20813559, moduleTitle=Inovio宣布DNA免疫疗法治疗宫颈癌变创新药III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11df20813559)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285979, encodeId=aafa12859e952, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=建立“5+3”人才培养体系河南一揽子措施加快医学教育创新发展, objectType=article, longId=208067, objectId=080a20806e9d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=080a20806e9d, replyNumber=0, likeNumber=55, createdTime=2021-03-08, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=080a20806e9d, moduleTitle=建立“5+3”人才培养体系河南一揽子措施加快医学教育创新发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=080a20806e9d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285980, encodeId=c59b1285980d9, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=多位代表委员建言中医药现代化：创新勿忘守正加强药材追溯, objectType=article, longId=208043, objectId=a6fa20804329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6fa20804329, replyNumber=0, likeNumber=65, createdTime=2021-03-08, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6fa20804329, moduleTitle=多位代表委员建言中医药现代化：创新勿忘守正加强药材追溯, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6fa20804329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285978, encodeId=915412859e8ba, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=默克与广药集团达成战略合作，推动大湾区业务创新发展, objectType=article, longId=207775, objectId=a45620e775a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a45620e775a9, replyNumber=0, likeNumber=59, createdTime=2021-03-02, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a45620e775a9, moduleTitle=默克与广药集团达成战略合作，推动大湾区业务创新发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a45620e775a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285977, encodeId=1c3d12859e713, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=超30亿，口服小分子药物License out创新记录, objectType=article, longId=207620, objectId=e0b620e6202d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0b620e6202d, replyNumber=0, likeNumber=70, createdTime=2021-02-27, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0b620e6202d, moduleTitle=超30亿，口服小分子药物License out创新记录, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0b620e6202d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285976, encodeId=1f8012859e65b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=Lancet子刊：国内创新药哌罗替尼有望成为HER2阳性乳腺癌替代治疗药物, objectType=article, longId=207595, objectId=f31120e5958c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f31120e5958c, replyNumber=0, likeNumber=51, createdTime=2021-02-27, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f31120e5958c, moduleTitle=Lancet子刊：国内创新药哌罗替尼有望成为HER2阳性乳腺癌替代治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f31120e5958c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285975, encodeId=f2be12859e54c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=默沙东收购华人研发新冠肺炎创新药物，有望成为新冠重症特效药物, objectType=article, longId=207352, objectId=186420e352dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=186420e352dd, replyNumber=0, likeNumber=71, createdTime=2021-02-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=186420e352dd, moduleTitle=默沙东收购华人研发新冠肺炎创新药物，有望成为新冠重症特效药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=186420e352dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285974, encodeId=065d12859e4bd, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=JAMA子刊：吃货福利——无需管住嘴，创新药有望实现减脂增肌降血糖！, objectType=article, longId=207079, objectId=4c2e20e079fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c2e20e079fb, replyNumber=0, likeNumber=71, createdTime=2021-02-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c2e20e079fb, moduleTitle=JAMA子刊：吃货福利——无需管住嘴，创新药有望实现减脂增肌降血糖！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c2e20e079fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285973, encodeId=5d4e12859e3b4, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=汇总：2020年NMPA共批准创新药48个，接近FDA水平, objectType=article, longId=206837, objectId=e42b20683e1f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e42b20683e1f, replyNumber=0, likeNumber=82, createdTime=2021-02-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e42b20683e1f, moduleTitle=汇总：2020年NMPA共批准创新药48个，接近FDA水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e42b20683e1f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285972, encodeId=4da912859e28d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=对话李开复：医疗产业重塑是巨大机会，创新工场将全面布局, objectType=article, longId=206822, objectId=af032068220e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af032068220e, replyNumber=0, likeNumber=78, createdTime=2021-02-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af032068220e, moduleTitle=对话李开复：医疗产业重塑是巨大机会，创新工场将全面布局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af032068220e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

精鼎医药与北京病痛挑战公益基金会建立创新合作，助力提升患者在临床试验中的体验

2021-04-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

以创新续写胰岛素百年传奇，赛诺菲助力糖尿病患者摆脱“甜蜜负担”

2021-04-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

长三角AI影像论坛在沪举行权威大咖力推AI临床创新

2021-04-10

lilianxiang (审核中...)

前往app查看评论内容

#创新#

中国自主创新微球制剂瑞欣妥®上市，以全球领先微球技术提升精神分裂症临床获益

2021-04-05

lilianxiang (审核中...)

前往app查看评论内容

#创新#

守护医护安全，创新质惠中国：碧迪医疗全球独创BD Vacutainer® V质管重磅上市

2021-03-19

lilianxiang (审核中...)

前往app查看评论内容

#创新#

荣昌生物创新药泰它西普在中国正式获批

2021-03-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

医美科技创新云第二届肉毒毒素联合论坛

2021-03-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021RWE真实世界研究峰会（第五届）创新变革规范中国-上海 2021.04.23-24

2021-03-13

lilianxiang (审核中...)

前往app查看评论内容

#创新#

创新肺纤维化靶向药维加特®医保落地，患者自付费用大降90%

2021-03-09

lilianxiang (审核中...)

前往app查看评论内容

#创新#

新版医保目录自3月1日起执行，原研SGLT2抑制剂（艾托格列净）价格再创新低！

2021-03-09

lilianxiang (审核中...)

前往app查看评论内容

#创新#

Inovio宣布DNA免疫疗法治疗宫颈癌变创新药III期临床成功

2021-03-09

lilianxiang (审核中...)

前往app查看评论内容

#创新#

建立“5+3”人才培养体系河南一揽子措施加快医学教育创新发展

2021-03-08

lilianxiang (审核中...)

前往app查看评论内容

#创新#

多位代表委员建言中医药现代化：创新勿忘守正加强药材追溯

2021-03-08

lilianxiang (审核中...)

前往app查看评论内容

#创新#

默克与广药集团达成战略合作，推动大湾区业务创新发展

2021-03-02

lilianxiang (审核中...)

前往app查看评论内容

#创新#

超30亿，口服小分子药物License out创新记录

2021-02-27

lilianxiang (审核中...)

前往app查看评论内容

#创新#

Lancet子刊：国内创新药哌罗替尼有望成为HER2阳性乳腺癌替代治疗药物

2021-02-27

lilianxiang (审核中...)

前往app查看评论内容

#创新#

默沙东收购华人研发新冠肺炎创新药物，有望成为新冠重症特效药物

2021-02-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

JAMA子刊：吃货福利——无需管住嘴，创新药有望实现减脂增肌降血糖！

2021-02-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

汇总：2020年NMPA共批准创新药48个，接近FDA水平

2021-02-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

对话李开复：医疗产业重塑是巨大机会，创新工场将全面布局

2021-02-07

科室
- - 订阅+
  - 更多科室
工具
服务